Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | CHRNB3 | Q05901 | 1/20 | 0.33 |
| ▸ | CHRNA6 | Q15825 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | TACR1 | P25103 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25872053 | 0.85 | POLB (0.34) | PIK3CDPOLBL3MBTL1HRH3CYP2D6 | |
| SCHEMBL26763784 | 0.81 | PIK3CD (0.38) | PIK3CDPOLBL3MBTL1CHRNB2CHRNA3 | |
| SCHEMBL20314875 | 0.80 | JAK3 (0.34) | POLBL3MBTL1 | |
| SCHEMBL27230523 | 0.79 | TACR1 (0.39) | PIK3CDPOLBL3MBTL1CHRNB2CHRNA3 | |
| SCHEMBL27209164 | 0.79 | TACR1 (0.39) | PIK3CDPOLBL3MBTL1CHRNB2CHRNA3 | |
| SCHEMBL25540243 | 0.78 | DPP4 (0.37) | POLBL3MBTL1HRH3CYP2D6KCNH2 | |
| SCHEMBL26030107 | 0.78 | KCNH2 (0.34) | POLBL3MBTL1HRH3CYP2D6KCNH2 | |
| SCHEMBL23876806 | 0.77 | PIK3CD (0.40) | PIK3CDCHRNB2CHRNA3CHRNA4CHRNB3 | |
| SCHEMBL26546789 | 0.77 | NR1H2 (0.41) | HRH3TACR1 | |
| SCHEMBL25872056 | 0.77 | NR1H2 (0.41) | HRH3TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4001269-A1 | BENZOISOTHIAZOLE, ISOTHIAZOLO[3,4-B]PYRIDINE, QUINAZOLINE, PHTHALAZINE, PYRIDO[2,3-D]PYRIDAZINE AND PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AS KRAS G12C INHIBITORS FOR TREATING LUNG, PANCREATIC OR COLORECTAL CANCER | Amgen Inc. (US) | 2022-05-25 | — | — | EP | disclosed |